Drug
Sparc1028
Sparc1028: highest development phase Phase 1, developed by Sun Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| SPARC1028 NCT01305512 | Phase 1 | Solid Tumor in Advanced Stage |
Latest
No recent events.
Follow Sparc1028 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.